论文部分内容阅读
应用抗腺病毒、呼吸道合胞病毒免疫核糖核酸(ADV-iRNA、RSV-iRNA)治疗病毒性肺炎43例。结果疗程缩短、治愈率提高、总有效率为95.4%。并增强机体对非特异性PHA皮肤反应及提高粒细胞吞菌率、杀菌率。
43 cases of viral pneumonia were treated with anti-adenovirus and RSV-iRNA. Results shorter course of treatment, the cure rate increased, the total effective rate was 95.4%. And enhance the body’s response to non-specific skin PHA and improve granulocyte phagocytosis rate, sterilization rate.